Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin
Podcast: JAMA Clinical ReviewsPublished On: Tue Mar 24 2020
Description: Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.
The note was deleted
The note was saved
Your message was sent